Study Title: A Phase II Trial of Chemotherapy plus Pembrolizumab in patients with advanced NSCLC previously treated with PD-1 or PD-L1 Inhibitor: Big Ten Cancer Research Consortium BTCRC-LUN15-029

• Status: Completed
• Participating sites:
  • University of Illinois Cancer Center
  • Indiana University Melvin and Bren Simon Comprehensive Cancer Center
  • Holden Comprehensive Cancer Center, University of Iowa
  • Masonic Cancer Center, University of Minnesota
  • University of Wisconsin Carbone Cancer Center, University of Iowa
• Learn more:
  • clinicaltrials.gov: NCT03083808
  • Big Ten CRC News Release
• Publications and Presentations:
  • Poster Session: 2021 ASCO Annual Meeting

Study Contact: studies@hoosiercancer.org; (317) 921-2050.